Read more

September 03, 2021
1 min read
Save

Top in rheumatology: Guidance on booster shots, vaccine response in patients with lupus

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

The American College of Rheumatology recommended that patients with rheumatic diseases who are on immunosuppressants receive a third dose of an mRNA COVID-19 vaccine. It was the top story in rheumatology last week.

Another top story included data revealing a low COVID-19 vaccine response rate in patients with lupus. Peter M. Izmirly, MD, of the New York University Grossman School of Medicine, said the finding supports previous data that suggest “patients on certain immunosuppression have a blunted effect to the COVID-19 vaccine.”

COVID19 vaccine vials
The American College of Rheumatology has recommended a third dose of the mRNA vaccine in those receiving immunosuppressive or immunomodulatory therapy. Source: Adobe Stock.

Read these and more top stories in rheumatology below:

ACR recommends booster dose of COVID-19 mRNA vaccine for patients on immunosuppressants

The American College of Rheumatology has updated its COVID-19 vaccine clinical guidance for patients with rheumatic diseases to recommend a third dose of the mRNA vaccine in those receiving immunosuppressive or immunomodulatory therapy. Read more.

Nearly 30% of patients with lupus show low response to COVID-19 vaccine

About 29% of patients with systemic lupus erythematosus demonstrate low response to the COVID-19 vaccine, with immunosuppression therapy associated with decreased protection, according to data published in Arthritis & Rheumatology. Read more.

Physician's exercise recommendations 'critical' to relieving arthritis symptoms

Among patients with arthritis, receiving exercise recommendations from a physician is “critical” to meeting physical activity guidelines and relieving symptom burden, regardless of race and ethnicity, researchers noted in BMC Public Health. Read more.

Amid growing cannabis access, data for rheumatology benefit still 'fraught with bias'

There is no doubt that patients with rheumatic and autoimmune diseases are taking full advantage of relaxed laws in the United States surrounding recreational cannabis use. Read more.

'Gout-36' rule simple, sensitive for classifying flare risk in hospitalized patients

A group of researchers have developed a rule that can help identify patients at high risk for gout flare during a hospital stay, according to data published in Rheumatology. Read more.